MyHealthcare ropes in Diwakar Bhowmik as COO

IMT News Desk
IMT News Desk
· 2 min read

Bhowmick is an accomplished healthcare IT professional with over 25 years of experience

MyHealthcare announced the appointment of Diwakar Bhowmik as Co-Founder and Chief Operating Officer (COO). Bhowmick is an accomplished healthcare IT professional with over 25 years of experience. He will join the founding team, bringing his expertise to drive MyHealthcare’s strategic expansion across India, South-East Asia, and the Middle East.

Bhowmik has been instrumental in the development and implementation of Hospital Information and Management Systems (HIMS) across prominent hospitals, both in India and globally. Since joining MyHealthcare in 2020, Bhowmik has led the MyHealthcare Enterprise Application (MHEA), combining best practices with cutting-edge digital solutions to build a comprehensive healthcare ecosystem, driving efficiency across hospital operations and a clinical ecosystem that delivers better patient care outcomes.

MyHealthcare’s Founder and CEO, Shyatto Raha, said, “We are thrilled to welcome Bhowmik to our founding team. His extensive expertise and functional knowledge in healthcare technology and dedication to advancing digital solutions in patient care make him an invaluable addition to the founding team of MyHealthcare. Diwakar’s experience aligns perfectly with our mission to use technology and a data-driven clinical ecosystem to deliver effective and quality healthcare for all. We are confident that his leadership will play a pivotal role in driving growth and success at MyHealthcare.”

In his new role, Bhowmik will oversee MyHealthcare’s operations and strategic planning, as the company expands its business across India, Asia, the Middle East and Africa. 

Bhowmik shared, “I am deeply honoured to step into this new role and join the founding team at MyHealthcare. I look forward to working with Divya, Aneesh and Shyatto in contributing to MyHealthcare’s vision of building an effective & innovative technology-driven ecosystem to deliver patient-centric healthcare solutions. The opportunity to work alongside a talented and passionate team, united by a shared vision of improving healthcare delivery, is truly inspiring. We are at an interesting growth phase at MyHealthcare, with geographical expansion and product innovation becoming a key agenda for us, in making a meaningful impact on healthcare delivery.”

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk